Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

Published:2018-10-05 Issue:6 Volume:1 Page:e183213
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Zhang Yaojun¹²³,Zhang Mengping⁴,Chen Minshan¹²³,Mei Jie⁵,Xu Li¹²³,Guo Rongping¹²³,Lin Xiaojun¹²³,Li Jiaping⁶,Peng Zhenwei⁴⁵

Affiliation:

1. Cancer Center, Sun Yat-sen University, Guangzhou, China

2. State Key Laboratory of Oncology in South China, Guangzhou, China

3. Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

4. Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

5. Clinical Trials Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

6. Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/1/6/e183213/17300688/zhang_2018_oi_180151.pdf

Reference28 articles.

1. Hepatocellular carcinoma.;Forner;Lancet,2012

2. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma.;Bruix;Gastroenterology,2016

3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.;European Association for the Study of the Liver;J Hepatol,2012

4. Management of hepatocellular carcinoma: an update.;Bruix;Hepatology,2011

5. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival.;Llovet;Hepatology,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning to estimate response of concurrent chemoradiotherapy in non-small-cell lung carcinoma;2024-09-09

2. Long-Term Outcomes of Balloon TACE for HCC: An European Multicentre Single-Arm Retrospective Study;CardioVascular and Interventional Radiology;2024-07-02

3. Prognostic Role of Lymphocyte-to-Monocyte Ratio (LMR) in Patients with Intermediate-Stage Hepatocellular Carcinoma (HCC) Undergoing Chemoembolizations (DEM-TACE or cTACE) of the Liver: Exploring the Link between Tumor Microenvironment and Interventional Radiology;Diseases;2024-06-27

4. A Multicenter International Retrospective Investigation Assessing the Prognostic Role of Inflammation-Based Scores (Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios) in Patients with Intermediate-Stage Hepatocellular Carcinoma (HCC) Undergoing Chemoembolizations of the Liver;Cancers;2024-04-23

5. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial);CardioVascular and Interventional Radiology;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3